Morgan Stanley’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.44M Sell
511,408
-340,021
-40% -$5.6M ﹤0.01% 3836
2026
Q1
$13.9M Sell
851,429
-115,281
-12% -$1.8M ﹤0.01% 3282
2025
Q4
$14.4M Sell
966,710
-252,043
-21% -$3.56M ﹤0.01% 3253
2025
Q3
$15.6M Sell
1,218,753
-267,202
-18% -$3.56M ﹤0.01% 3119
2025
Q2
$22.6M Buy
1,485,955
+310,914
+26% +$4.85M ﹤0.01% 2677
2025
Q1
$19.6M Buy
1,175,041
+55,113
+5% +$1.01M ﹤0.01% 2714
2024
Q4
$21.1M Sell
1,119,928
-975,754
-47% -$18.8M ﹤0.01% 2694
2024
Q3
$39.4M Buy
2,095,682
+396,776
+23% +$7.6M ﹤0.01% 2082
2024
Q2
$32.1M Sell
1,698,906
-394,617
-19% -$6.73M ﹤0.01% 2169
2024
Q1
$34M Sell
2,093,523
-2,901,983
-58% -$42.5M ﹤0.01% 2122
2023
Q4
$63.3M Buy
4,995,506
+3,214,960
+181% +$40.6M ﹤0.01% 2209
2023
Q3
$24.2M Buy
1,780,546
+67,877
+4% +$1.05M ﹤0.01% 2249
2023
Q2
$29.4M Buy
1,712,669
+205,656
+14% +$3.19M ﹤0.01% 2086
2023
Q1
$21M Sell
1,507,013
-409,587
-21% -$6.03M ﹤0.01% 2367
2022
Q4
$25.6M Sell
1,916,600
-49,593
-3% -$641K ﹤0.01% 2096
2022
Q3
$23.4M Sell
1,966,193
-32,526
-2% -$462K ﹤0.01% 2029
2022
Q2
$25.4M Buy
1,998,719
+460,772
+30% +$5.91M ﹤0.01% 2024
2022
Q1
$19.9M Sell
1,537,947
-71,641
-4% -$946K ﹤0.01% 2119
2021
Q4
$25.5M Buy
1,609,588
+823,424
+105% +$14.1M ﹤0.01% 1909
2021
Q3
$15.3M Buy
786,164
+22,028
+3% +$437K ﹤0.01% 2386
2021
Q2
$17.4M Sell
764,136
-70,748
-8% -$1.47M ﹤0.01% 2312
2021
Q1
$15.3M Sell
834,884
-261,440
-24% -$4.29M ﹤0.01% 2203
2020
Q4
$16.3M Buy
1,096,324
+569,393
+108% +$7.43M ﹤0.01% 2009
2020
Q3
$5.91M Sell
526,931
-52,189
-9% -$514K ﹤0.01% 2554
2020
Q2
$4.6M Sell
579,120
-1,047,477
-64% -$8.68M ﹤0.01% 2752
2020
Q1
$13.1M Buy
1,626,597
+608,317
+60% +$7.23M ﹤0.01% 1573
2019
Q4
$12.8M Buy
1,018,280
+195,914
+24% +$2.11M ﹤0.01% 2126
2019
Q3
$7.34M Sell
822,366
-89,927
-10% -$786K ﹤0.01% 2451
2019
Q2
$7.8M Buy
912,293
+69,654
+8% +$550K ﹤0.01% 2433
2019
Q1
$6.39M Sell
842,639
-384,003
-31% -$3.09M ﹤0.01% 2473
2018
Q4
$10.1M Sell
1,226,642
-9,725
-0.8% -$93K ﹤0.01% 2111
2018
Q3
$12.3M Buy
1,236,367
+733,851
+146% +$7.6M ﹤0.01% 2206
2018
Q2
$4.91M Sell
502,516
-143,411
-22% -$1.41M ﹤0.01% 3168
2018
Q1
$6M Sell
645,927
-248,869
-28% -$2.37M ﹤0.01% 2837
2017
Q4
$8.51M Buy
894,796
+134,653
+18% +$1.29M ﹤0.01% 2562
2017
Q3
$7.86M Buy
760,143
+303,277
+66% +$2.8M ﹤0.01% 2521
2017
Q2
$3.78M Sell
456,866
-61,110
-12% -$459K ﹤0.01% 3173
2017
Q1
$3.73M Sell
517,976
-101,358
-16% -$735K ﹤0.01% 3185
2016
Q4
$4.42M Buy
619,334
+527,572
+575% +$3.67M ﹤0.01% 3124
2016
Q3
$668K Sell
91,762
-1,383,847
-94% -$8.8M ﹤0.01% 4328
2016
Q2
$8.64M Buy
1,475,609
+1,324,380
+876% +$8.77M ﹤0.01% 2116
2016
Q1
$962K Buy
151,229
+15,008
+11% +$80.5K ﹤0.01% 3969
2015
Q4
$874K Sell
136,221
-1,133,123
-89% -$7.08M ﹤0.01% 4160
2015
Q3
$7.38M Buy
1,269,344
+840,272
+196% +$6.23M ﹤0.01% 2266
2015
Q2
$3.75M Buy
429,072
+71,024
+20% +$597K ﹤0.01% 3046
2015
Q1
$2.86M Sell
358,048
-462,191
-56% -$3.45M ﹤0.01% 3245
2014
Q4
$6.36M Sell
820,239
-466,320
-36% -$3.4M ﹤0.01% 2496
2014
Q3
$8.34M Buy
1,286,559
+488,132
+61% +$3.77M ﹤0.01% 2198
2014
Q2
$6.71M Buy
798,427
+173,256
+28% +$1.34M ﹤0.01% 2398
2014
Q1
$4.2M Buy
625,171
+467,613
+297% +$2.84M ﹤0.01% 2741
2013
Q4
$986K Sell
157,558
-731,707
-82% -$3.57M ﹤0.01% 3944
2013
Q3
$3.87M Sell
889,265
-261,925
-23% -$1.2M ﹤0.01% 2678
2013
Q2
$5.09M Buy
+1,151,190
New +$5.1M ﹤0.01% 2310

Other funds holding SEM

Morgan Stanley's SEM Position: Q2 2026 in Review

Morgan Stanley reduced its Select Medical (SEM) stake by 40% in Q2 2026, selling an estimated $5.6M and leaving 511,408 shares worth $8.44M. The position accounts for ﹤0.01% of the portfolio, ranked #3836.

Morgan Stanley first reported a position in SEM in Q2 2013 and has held it in 53 quarters since. The position peaked at $63.3M in Q4 2023. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

  • Morgan Stanley held 511,408 shares of Select Medical worth $8.44M as of Q2 2026.
  • Morgan Stanley sold 340,021 Select Medical shares in Q2 2026, an estimated $5.6M.
  • Select Medical made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #3836 holding.
  • Morgan Stanley first reported a position in Select Medical in Q2 2013 and has held it in 53 quarters since.
  • Morgan Stanley's Select Medical position peaked at $63.3M in Q4 2023.
  • 238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.